Pluribus Labs’s Blackrock BLK Stock Holding History

Pluribus Labs’s Portfolio BLK Stock Details BLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$705K	Buy	1,157 +680	+143%	+$443K	1.29%	18
2022 Q1	$365K	Buy	+477	New	+$373K	1.45%	19

Other funds holding BLK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Pluribus Labs's BLK Position: Q2 2022 in Review

Pluribus Labs increased its Blackrock (BLK) stake by 143% in Q2 2022, buying an estimated $443K and bringing the position to 1,157 shares worth $705K. The position accounts for 1.29% of the portfolio, ranked #18.

Pluribus Labs first reported a position in BLK in Q1 2022 and has held it in 2 quarters since. 1,750 funds tracked by Wall St. Rank hold BLK as of Q2 2022.

Pluribus Labs held 1,157 shares of Blackrock worth $705K as of Q2 2022.
Pluribus Labs bought 680 Blackrock shares in Q2 2022, an estimated $443K.
Blackrock made up 1.29% of Pluribus Labs's portfolio in Q2 2022, its #18 holding.
Pluribus Labs first reported a position in Blackrock in Q1 2022 and has held it in 2 quarters since.
1,750 funds tracked by Wall St. Rank held Blackrock as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.